Abeona Therapeutics Inc (ABEO) — Cash Flow Quality Index

Latest as of June 2025: -0.17x

Abeona Therapeutics Inc (ABEO) has a Cash Flow Quality Index of -0.17x as of June 2025. Operating cash flow of $-18.78 Million is below net income of $108.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore ABEO asset base for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.17x
Operating CF / Net Income

Operating Cash Flow

$-18.78 Million
USD

Net Income

$108.83 Million
USD

Data as of

Jun 2025
Most recent filing

Abeona Therapeutics Inc Cash Flow Quality Index (1995–2025)

Historical Cash Flow Quality Index for Abeona Therapeutics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ABEO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Abeona Therapeutics Inc (1995–2025)

Year-by-year earnings quality comparison for Abeona Therapeutics Inc. For live market cap and the full company financial profile, see market value of Abeona Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2025 -1.07x $-76.33 Million $71.18 Million ▼ -477144.2%
2013 0.00x $1.00K $4.45 Million ▼ -100.0%
1995 1.93x $658.00K $341.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.